Press release
Post-Operative Cataract Surgery Inflammation Pipeline, Treatment Drugs, Clinical Trials, and Companies 2024
Discover the latest drugs and treatment options in the Post-Operative Cataract Surgery Inflammation Pipeline. Dive into DelveInsight's comprehensive report today! @ Post-Operative Cataract Surgery Inflammation Pipeline Outlook [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Post-Operative Cataract Surgery Inflammation Pipeline Report
* In January 2024:- Oculis- This is a multi-center, randomized, double-masked, vehicle-controlled study, designed to evaluate the efficacy and safety of OCS-01 compared to vehicle in treating inflammation and pain following cataract surgery. Subjects will be randomized 1:1 to receive OCS-01 or vehicle once daily. The goal of this clinical trial is to evaluate the efficacy and safety of OCS-01 in treating inflammation and pain in subjects following cataract surgery.
* DelveInsight's Post-Operative Cataract Surgery Inflammation pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Post-Operative Cataract Surgery Inflammation treatment.
* The leading Post-Operative Cataract Surgery Inflammation Companies such as Oculis, Formosa Pharmaceuticals, VisusNano, Surface Ophthalmics , and others.
* Promising Post-Operative Cataract Surgery Inflammation Therapies such as Dexamethasone, OCS-01 , and others
Stay ahead with the most recent pipeline outlook for Post-Operative Cataract Surgery Inflammation. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Post-Operative Cataract Surgery Inflammation Treatment Drugs [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Post-Operative Cataract Surgery Inflammation Emerging Drugs Profile
* APP13007: Formosa Pharmaceuticals
APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension), a novel formulation of the potent corticosteroid, clobetasol propionate, for the treatment of inflammation and pain after cataract surgery. APP13007 was developed, improves the dissolution and bioavailability of APIs for topical, oral, and inhaler administration.
Explore groundbreaking therapies and clinical trials in the Post-Operative Cataract Surgery Inflammation Pipeline. Access DelveInsight's detailed report now! @ New Post-Operative Cataract Surgery Inflammation Drugs [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Post-Operative Cataract Surgery Inflammation pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
* Intranasal
* Intrathecal
* Intravenous
* Oral
* Oral/Intravenous
* Parenteral
* Subcutaneous
* Subcutaneous/Intramuscular
* Transdermal
Post-Operative Cataract Surgery Inflammation Products have been categorized under various Molecule types such as
* Antisense oligonucleotide
* Gene therapy
* Hormones
* Neuropeptides
* Oligonucleotides
* Small Molecule
* Triglyceride
Unveil the future of Post-Operative Cataract Surgery Inflammation Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Post-Operative Cataract Surgery Inflammation Market Drivers and Barriers [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Post-Operative Cataract Surgery Inflammation Pipeline Report
* Coverage- Global
* Post-Operative Cataract Surgery Inflammation Companies- Oculis, Formosa Pharmaceuticals, VisusNano, Surface Ophthalmics, and others.
* Post-Operative Cataract Surgery Inflammation Therapies- Dexamethasone, OCS-01, and others.
* Post-Operative Cataract Surgery Inflammation Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Post-Operative Cataract Surgery Inflammation Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Post-Operative Cataract Surgery Inflammation Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Post-Operative Cataract Surgery Inflammation Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/post-operative-cataract-surgery-inflammation-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Post-Operative Cataract Surgery Inflammation: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Post-Operative Cataract Surgery Inflammation- DelveInsight's Analytical Perspective
* Mid Stage Products (Phase III)
* APP13007: Formosa Pharmaceuticals
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Drug name: Company name
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I/II)
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug name: Company name
* Drug profiles in the detailed report.....
* Preclinical Stage Products
* Drug name: Company name
* Drug profiles in the detailed report.....
* Inactive Products
* Post-Operative Cataract Surgery Inflammation Key Companies
* Post-Operative Cataract Surgery Inflammation Key Products
* Post-Operative Cataract Surgery Inflammation- Unmet Needs
* Post-Operative Cataract Surgery Inflammation- Market Drivers and Barriers
* Post-Operative Cataract Surgery Inflammation- Future Perspectives and Conclusion
* Post-Operative Cataract Surgery Inflammation Analyst Views
* Post-Operative Cataract Surgery Inflammation Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=postoperative-cataract-surgery-inflammation-pipeline-treatment-drugs-clinical-trials-and-companies-2024]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Post-Operative Cataract Surgery Inflammation Pipeline, Treatment Drugs, Clinical Trials, and Companies 2024 here
News-ID: 3681106 • Views: …
More Releases from ABNewswire
Red Teaming vs Penetration Testing: Understanding the Difference
Image: https://www.abnewswire.com/upload/2025/12/bc1e8a773c50dd0c9305d06207de098f.jpg
The topic of red teaming vs penetration testing often creates confusion among security teams, decision-makers and technical stakeholders. Both approaches aim to uncover weaknesses, yet they work in very different ways. Many organisations rely on one method thinking it covers the role of the other. This misunderstanding can lead to gaps in visibility, unclear expectations and misplaced confidence.
A clearer view of pentest vs red team helps organisations make better…
Suburban Solutions Moving Announces New West Chester, PA Location to Strengthen …
West Chester, PA - Suburban Solutions [https://suburbansolutions.com/], a highly trusted and fast-growing moving company serving the Greater Philadelphia and Washington, DC regions, is proud to announce the opening of its newest location at 1271 Upton Cir, West Chester, PA 19380. This expansion marks an important step in the company's ongoing mission to provide dependable and accessible relocation support to more communities across Pennsylvania.
With this new branch, Suburban Solutions Moving aims…
LSLONG Launches New Premium Custom Polo Shirt Collection with Full OEM & ODM Sup …
Shenzhen LSLONG Garments Co., Ltd., a global leader in apparel manufacturing, has officially unveiled its new Premium Custom Polo Shirt [https://www.lslt-shirt.com/polo-shirt-categories/] Collection, combining advanced fabrics, innovative designs, and end-to-end customization solutions. This launch underscores LSLONG's 25 years of experience delivering high-quality OEM and ODM apparel services to brands across more than 50 countries. The collection aims to empower brands with versatile, stylish, and performance-driven Polo shirts while providing comprehensive support…
Arteestry Creations Plus Brings Unique Customizable Designs to Over 50 Product C …
Arteestry Creations Plus offers creative custom designs across an extensive range of products from apparel to home goods to magnets, serving customers seeking personalized items for holidays, special occasions, and everyday use. The growing e-commerce brand combines artistic creativity with broad product versatility, featuring licensed collections from Disney, Pixar, Marvel, and Star Wars alongside original designs that can be applied across different product types upon customer request.
Arteestry Creations Plus has…
More Releases for Cataract
Transformative Trends Impacting the Cataract Surgery Devices And Equipment Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cataract Surgery Devices And Equipment Market Size By 2025?
The market size for cataract surgery devices and equipment has shown a consistent growth trend in recent years. It is projected to increase from $13.97 billion in 2024 to $14.52 billion in 2025, exhibiting a compound…
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying alternatives to conventional cataract extraction surgery. Advances in molecular biology, oxidative stress modulation, and crystallin protein stabilization have opened new avenues for pharmacological intervention. Companies like Nacuity Pharmaceuticals, CGeneTech, and Plex Pharmaceuticals are pioneering efforts to develop novel agents aimed at delaying, halting, or reversing…
Cataract Surgery Devices Market - Innovation Meets Precision: Elevate Cataract S …
Newark, New Castle, USA: The "Cataract Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cataract Surgery Devices Market: https://www.growthplusreports.com/report/cataract-surgery-devices-market/7846
This latest report researches the industry structure,…
Intraocular Lens Implants for Cataract Market is Driven by the Increasing Incide …
The proposed Intraocular Lens Implants for Cataract Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.
The Intraocular Lens Implants for Cataract Market…
Potential Opportunities of Cataract Surgical Devices Market
The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user…
Cataract Surgery Devices Market Opportunity Analysis, 2018-2026
Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes.
Although cataract does not interfere with the eyesight in the early stages, it…
